Psychedelic

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Vancouver, Canada, April 08, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind” or the "Company"), a...

European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures

The European Commission has officially registered the PsychedeliCare initiative, which advocates for establishing a transnational legal framework for psychedelic-assisted treatments...

Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally – Enveric Biosciences (NASDAQ:ENVB)

Psychedelics biotech Enveric Biosciences ENVB announced positive preclinical results of its EB-003 drug candidate to be delivered via oral administration....